Impact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma.

Gastrointest Tumors

Division of Molecular and Genetic Medicine, Department of Genetic Medicine and Regenerative Therapeutics, Graduate School of Medicine, Tottori University, Yonago, Japan.

Published: March 2017

AI Article Synopsis

  • - Retinoids, which are derivatives of vitamin A, show potential antitumor effects against hepatocellular carcinoma (HCC), but their action can be inhibited by the protein PRAME, which interferes with retinoic acid signaling.
  • - A study analyzed PRAME mRNA expression in cancer and non-cancer tissues from 100 HCC patients, revealing key connections between PRAME levels, cancer stage, tumor markers, and patient survival outcomes.
  • - The research suggests that PRAME could serve as a new prognostic marker for HCC, even though its mechanism of action doesn't directly involve the RA transcriptional pathway.

Article Abstract

Background: Retinoids, vitamin A and its derivatives, have an antitumor effect on hepatocellular carcinoma (HCC). The function of retinoids is exerted by the complex of retinoic acid (RA) with the heterodimer of retinoid X receptor and the RA receptor. The preferentially expressed antigen of melanoma (PRAME) acts as a dominant repressor of RA signaling by binding to the complex. The significance of PRAME on the prognosis of HCC remains to be clarified.

Methods: PRAME mRNA expression was examined by quantitative real-time polymerase chain reaction in both tumor and non-tumor tissues of 100 HCC patients who received surgical resection. The effect of PRAME knockdown on DR5-mediated RA transcriptional activity was examined.

Results: In tumor tissues, there were significant associations among PRAME expression, clinical stage, tumor markers, and tumor numbers. In non-tumor tissues, there were significant associations among PRAME expression, overall survival, and disease-free survival. The knockdown of PRAME caused no reduction in DR5-mediated transcriptional activity of RA, suggesting that PRAME acts via other mechanisms than the DR5 RA-responsive elements.

Conclusion: Our findings indicate that PRAME expression is a novel prognostic marker in HCC patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465675PMC
http://dx.doi.org/10.1159/000448137DOI Listing

Publication Analysis

Top Keywords

prame expression
12
prame
9
preferentially expressed
8
expressed antigen
8
antigen melanoma
8
hepatocellular carcinoma
8
prame acts
8
non-tumor tissues
8
hcc patients
8
dr5-mediated transcriptional
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!